Interim Report Q3 – July – September, 2021 Redsense Medical AB (publ)
July – September 2021 · Net sales amounted to kSEK 3,566 (2,107), a 69 percent increase compared with the corresponding period in 2020. · Profit or loss before tax amounted to kSEK -2,547 (-3,213). · Earnings per share before dilution amounted to SEK -0.18. January – September 2021 · Net sales amounted to kSEK 6,008 (12,213), a 51 percent decrease compared with the corresponding period in 2020. · Profit or loss before tax amounted to kSEK -6,937 (-2,958). · Total equity amounted to kSEK 38,904 at the end of the period. · Cash and cash equivalents amounted to kSEK